Ell P J, Costa D C
Institute of Nuclear Medicine, University College and Middlesex School of Medicine, London, UK.
Curr Opin Neurol Neurosurg. 1992 Dec;5(6):863-9.
Nuclear medicine has a place in the study of brain trauma, brain tumours, stroke, dementia epilepsy and depression. The development of new tracers labelled with widely available radionuclides, such as technetium-99m (99Tc) and iodine-123, has played a key role here. Practical methodology can now be implemented in the routine setting. Additional applications are reviewed in the context of brain death, encephalitis, post-viral fatigue syndrome, Parkinson's disease and schizophrenia.
核医学在脑外伤、脑肿瘤、中风、痴呆、癫痫和抑郁症的研究中占有一席之地。用广泛可得的放射性核素标记的新型示踪剂的开发,如锝-99m(99Tc)和碘-123,在此发挥了关键作用。现在可以在常规环境中实施实用的方法。在脑死亡、脑炎、病毒后疲劳综合征、帕金森病和精神分裂症的背景下对其他应用进行了综述。